The Systemic Shift in Emergency Analgesia
The management of acute pain in emergency departments (EDs) has long been a focal point of public health concern. For decades, the reliance on powerful opioids served as the clinical standard, yet the subsequent proliferation of these prescriptions contributed significantly to the first wave of the US opioid crisis starting in the 1990s. This systemic failure highlighted a critical gap in healthcare: the need for effective pain relief that does not carry the high risk of addiction and overdose.
Modern healthcare systems are now pivoting toward multimodal analgesia-the use of multiple classes of medications to achieve pain relief. This strategy aims to reduce the total dose of any single high-risk drug, thereby mitigating side effects while maintaining therapeutic efficacy. The goal is to move away from a “one-size-fits-all” approach to pain and instead implement a precise, targeted strategy based on the specific nature of the patient’s distress.
Within this shift, emergency departments sit at the intersection of individual suffering and population-level risk. They are under growing scrutiny from regulators and hospital leaders as frontline implementers of opioid stewardship programs, which seek to align day-to-day prescribing with national guidance from agencies such as the Centers for Disease Control and Prevention.
Diversifying the Clinical Toolbox for Acute Pain
Research conducted at the University of California, San Francisco (UCSF) emphasizes the importance of expanding the options available to emergency physicians. Akash Shanmugam, a medical student at UCSF, noted that the objective was to “create a very targeted list for specific pain conditions” to help add to the “toolboxes” physicians use to treat patients.
While acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen remain versatile options capable of treating various pain types, other medications offer more specialized applications for common emergency presentations. This reflects a broader move toward structured, protocol-driven multimodal analgesia, in which combinations of non-opioid agents are deliberately selected to address different pain pathways and reduce overall opioid exposure.[3]
| Pain Presentation in the ED | Targeted Non-Opioid or Opioid-Sparing Option |
|---|---|
| Chest Pain (select cases, e.g., severe trauma or procedural sedation) | Ketamine (dissociative anaesthetic with analgesic properties) |
| Back Pain, Neuropathic Features | Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) |
| Severe Headache & Abdominal Pain | Specific Antipsychotic Medications, used off-label in monitored settings |
| General or Mild-to-Moderate Acute Pain | Acetaminophen and NSAIDs (e.g., ibuprofen) |
This diversification is not merely about avoiding opioids, but about recognizing that different physiological pathways drive different types of pain. For instance, the use of psychotropic medications for pain is rooted in the overlap between mood regulation and sensory perception. Shanmugam pointed out that gabapentin was first approved as “a really mediocre” drug for epilepsy, but “now it’s used a lot for the management of neuropathic pain.”
In practice, these choices are increasingly encoded into hospital order sets and enhanced recovery pathways, nudging clinicians toward evidence-based, non-opioid-first regimens while still allowing room for clinical judgment and escalation when pain remains uncontrolled.[2]
The Intersection of Neuroscience and Pain Perception
The efficacy of non-opioid alternatives, particularly antidepressants and antipsychotics, lies in their ability to modulate neurotransmitters such as dopamine, serotonin, norepinephrine, and glutamate. These chemicals do not just regulate mood; they are integral to how the brain processes pain.
The relationship between physical sensation and emotional distress is deeply intertwined. Shanmugam explained that “neural circuits that create the sensation of pain are also are involved in the emotional experience of pain, and the distress that pain produces for human beings.”
In cases of prolonged or severe distress, the nervous system can enter a state of hyper-excitability. Dr. Kathy LeSaint, an associate professor of emergency medicine at UCSF, noted, “In chronic pain conditions, the nervous system can become highly sensitive, and it’s thought that antidepressants and antipsychotics can maybe reduce this heightened sensitivity in the brain.”
Furthermore, the systemic impact of pain often extends beyond the primary injury:
- Sleep Disruption: Acute and chronic pain often lead to insomnia, which lowers the pain threshold and can intensify the next day’s symptoms.
- Psychological Distress: Co-occurring anxiety and depression can amplify the physical experience of pain and complicate recovery.
- Physical Fatigue: Chronic pain syndromes often result in systemic exhaustion, making physical rehabilitation and return to work more difficult.
As Dr. LeSaint observed, “Chronic pain is often linked to things like poor sleep, depression, anxiety, fatigue,” suggesting that medications addressing these secondary symptoms can make the primary pain easier to manage. For policymakers and health-system executives, this neurobiological framing matters: it supports investment in integrated behavioral health and pain services, rather than treating pain as a siloed, purely somatic problem.
Integrating Personalized Medicine in Acute Care
The shift toward non-opioid alternatives also incorporates the principles of pharmacogenomics, recognizing that genetic variation dictates how individuals respond to medication. Dr. LeSaint explained that “the enzymes that are responsible for metabolizing opioids can have different strengths in people,” meaning a standard dose may be ineffective for one patient while being toxic to another.
In the ED, this often translates into a more cautious, stepwise approach: starting with non-opioid agents, reassessing frequently, and reserving opioids for cases in which benefits clearly outweigh risks. That approach is reinforced by national opioid prescribing guidelines issued by the Centers for Disease Control and Prevention, which frame opioid stewardship as a matter of both clinical quality and public health protection.[2]
However, the drive toward safer prescribing must be balanced with the clinical necessity of treating acute suffering. Both Shanmugam and LeSaint emphasize that opioids remain a necessary part of the medical arsenal. “The desire to reduce opioids shouldn’t come at the expense of under-treating pain,” Shanmugam said.
To ensure equitable and effective care, physicians are encouraged to prioritize patient history and communication. “Talking to them and asking about their prior experience with opioids prior to giving opioids can be really helpful in tailoring the pain regimen for that particular patient, for that particular pain syndrome,” LeSaint said. That dialogue also helps clinicians identify patients at higher risk of opioid-related harm-such as those with previous overdose, substance use disorder, or concurrent sedative use-so that dosing and follow-up can be adjusted accordingly.
A significant hurdle in utilizing psychotropic medications for pain is patient perception. There is often a stigma associated with these drugs, leading patients to believe their physical pain is being dismissed as psychological. To counter this, clinicians are using a science-based communication strategy.
“I’ve seen a lot of clinicians use the basic science approach of explaining that there’s a lot of overlap between the pain mechanisms and also the emotional understanding of pain,” Shanmugam said, adding that “that really helps reassure patients.”
By integrating evidence-based prescribing guidelines with a personalized approach, emergency departments can better manage the immediate needs of patients while protecting the broader public health from the long-term risks of opioid dependency. For hospital leaders, regulators, and health insurers, the message is converging: resourcing multimodal analgesia, supporting clinician training, and embedding these practices into routine ED care are no longer optional quality upgrades-they are central to how modern health systems balance compassion for the individual with responsibility to the wider community.
